Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 29, 2025, Q32 Bio (QTTB) has a market cap of $18.967 million USD. According to our data, Q32 Bio is ranked No.8584 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 29, 2025 | $18.97 M |
-54.73%
|
| Dec 31, 2024 | $41.90 M |
-68.57%
|
| Dec 29, 2023 | $0.13 B |
-51.75%
|
| Dec 30, 2022 | $0.28 B |
-65.38%
|
| Dec 31, 2021 | $0.80 B |
-67.76%
|
| Dec 31, 2020 | $2.48 B |
-45.46%
|
| Dec 31, 2019 | $4.54 B |
-7.42%
|
| Dec 31, 2018 | $4.90 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$152.20 B |
0.126 B
|
USA
|
 Biogen
BIIB
|
$17.59 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$62.20 B |
1.034 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$127.64 B |
0.004 M
|
USA
|
 Moderna
MRNA
|
$10.76 B |
0.000 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$12.13 B |
0.000 M
|
USA
|
 Illumina
ILMN
|
$12.20 B |
-0.000 M
|
USA
|
 Incyte
INCY
|
$11.69 B |
0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$33.29 B |
-0.001 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.98 B |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.23 B |
-0.000 M
|
Switzerland
|
 bluebird bio
BLUE
|
$40.34 M |
0.000 M
|
USA
|
 Editas Medicine
EDIT
|
$0.13 B |
0.000 M
|
USA
|
| Market Cap | = | QTTB Stock Price | * | QTTB Shares Outstanding |
| = | $1.55 | * | 12.20 M | |
| = | $18.97 M |